Literature DB >> 6771227

Antibiotic-resistant mutants of Mycoplasma pneumoniae.

T Stopler, C B Gerichter, D Branski.   

Abstract

Sensitivity tests of Mycoplasma pneumoniae to antibiotics were performed with 28 strains to determined the minimum inhibitory concentration (MIC) of the antibiotics, the MIC after 14 days' incubation at 37 C, and the minimum plasmacidal concentration. The antibiotics tested were erythromycin, tetracycline, oxytetracycline, chloramphenicol and streptomycin. The MIC of erythromycin was around 0.01 microgram/ml, whereas that of tetracycline was approximately 0.1 microgram/ml. Of the 28 strains tested, nine isolates gave rise to mutants resistant to high concentrations of erythromycin, chloramphenicol and streptomycin; none of the strains produced mutants resistant to tetracycline. Of the nine resistant mutants, three strains were isolated from erythromycin-treated patients. One strain, isolated from a patient treated with erythromycin for 18 days, was resistant to the antibiotic in a concentration greater than 100 microgram/ml.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771227

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  8 in total

1.  Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae.

Authors:  Satowa Suzuki; Tsutomu Yamazaki; Mitsuo Narita; Norio Okazaki; Isao Suzuki; Tomoaki Andoh; Mayumi Matsuoka; Tsuyoshi Kenri; Yoshichika Arakawa; Tsuguo Sasaki
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 2.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Antimycoplasmal activity of ofloxacin (DL-8280).

Authors:  Y Osada; H Ogawa
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

Review 4.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas.

Authors:  Ken B Waites; Donna M Crabb; Lynn B Duffy
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

6.  Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.

Authors:  T S Lucier; K Heitzman; S K Liu; P C Hu
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

7.  Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.

Authors:  Bernard J Wolff; W Lanier Thacker; Stephanie B Schwartz; Jonas M Winchell
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191

Review 8.  Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae.

Authors:  Tsutomu Yamazaki; Tsuyoshi Kenri
Journal:  Front Microbiol       Date:  2016-05-23       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.